Search Within

Mary Welch

Formats
  1. Meeting Abstract (8)
  2. Journal Article (3)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (6)
  3. Nursing (5)
  4. Center for Pancreatic Cancer Research (4)
  5. Gastrointestinal Oncology Service (4)
  6. Bone Marrow Transplant (2)

More Groups

People
  1. Antonio Omuro (5)
  2. Gary Schwartz (4)
  3. Sandra Endres (4)
  4. Andreas Kaubisch (2)
  5. Bradley Beattie (2)
  6. Craig Moskowitz (2)

More People

Years
  1. 2015 (1)
  2. 2012 (3)
  3. 2011 (1)
  4. 2004 (1)
  5. 2003 (1)
  6. 2002 (3)

More Years

Publications
  1. Neuro-Oncology (3)
  2. Journal of Nuclear Medicine (2)
  3. Proceedings of the American Association for Cancer Research Annual Meeting (2)
  4. Anti-Cancer Drugs (1)
  5. European Journal of Cancer (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Oxford University Press (3)
  2. American Association for Cancer Research (2)
  3. Society of Nuclear Medicine (2)
  4. American Society of Clinical Oncology (1)
  5. Elsevier Inc. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Autologous stem cell transplant in recurrent or refractory primary or secondary central nervous system lymphoma using thiotepa, busulfan and cyclophosphamide
    Journal Article

    Welch, M. R.; Sauter, C. S.; Matasar, M. J.; Faivre, G.; Weaver, S. A.; Moskowitz, C. H.; Omuro, A. M.
    Leukemia and Lymphoma (2015)

    Fulltext@MSK | Save
  • High-dose chemotherapy (HDC) followed by autologous stem cell transplant (ASCT) for recurrent/progressive CNS lymphoma
    Meeting Abstract

    Welch, M. R.; Sauter, C. S.; Matasar, M. J.; Moskowitz, C.; Omuro, A. M. P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Bevacizumab (BEV) in elderly patients with glioblastoma (GBM)
    Meeting Abstract

    Welch, M. R.; Omuro, A.; Grommes, C.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Outcomes of the oldest patients with primary CNS lymphoma treated at Memorial Sloan-Kettering Cancer Center
    Journal Article

    Welch, M. R.; Omuro, A.; De Angelis, L. M.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save
  • Outcome of the oldest old with primary central nervous system lymphoma (PCNSL) at Memorial Sloan-Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Welch, M. R.; Omuro, A.; Deangelis, L. M.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Phase I trial of sequential raltitrexed followed by bolus 5-fluorouracil in patients with advanced colorectal cancer
    Journal Article

    Schwartz, G. K.; Bertino, J.; Kemeny, N.; Saltz, L.; Kelsen, D.; Tong, W.; Welch, M.; Endres, S.; Dimery, I.
    Anti-Cancer Drugs (2004)

    Fulltext@MSK | Save
  • Tumor localization of [18F]-Fluoro-Dihydro-testosterone (FDHT) versus [18F]-2-Fluoro-D-glucose (FDG) in patients with progressive, metastatic prostate cancer
    Meeting Abstract

    Larson, S. M.; Gunther, I.; Morris, M.; Beattie, B.; Akhurst, T. A.; Finn, R.; Pentlow, K.; Zanzonico, P.; Erdi, Y.; Humm, J.; more...
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Response to the combination of bryostatin-1 and paclitaxel is dose-dependent
    Meeting Abstract

    Kortmansky, J.; Shah, M.; Ilson, D.; Kaubisch, A.; Endres, S.; Welch, M.; Gonen, M.; Kelsen, D. P.; Schwartz, G. K.
    Proceedings of the American Association for Cancer Research Annual Meeting (2002)

    Fulltext@MSK | Save
  • PET-based radiation dosimetry in man of F-18-fluorodihydrotestosterone (FDHT), a new radiotracer for imaging prostate cancer
    Meeting Abstract

    Zanzonico, P.; Finn, R.; Pentlow, K. S.; Erdi, Y.; Beattie, B.; Humm, J.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; more...
    Journal of Nuclear Medicine (2002)

    Fulltext@MSK | Save
  • Phase I and pharmacokinetic study of LY293111, an orally available small molecule known to be an LTB4 receptor antagonist, 5-lipoxygenase inhibitor and peroxisome proliferator activated receptor-gamma agonist (PPAR gamma)
    Meeting Abstract

    Budman, D. R.; Schwartz, G. K.; Endres, S.; Welch, M.; O'reilly, E.; Barile-Thiem, B.; Brail, L. H.; De Alwis, D. P.; Cleverly, A.; Weitzman, A.
    European Journal of Cancer (2002)

    Fulltext@MSK | Save